Dendritic Cells (T‐lymphocyte Stimulating)

Dendritic cells (DCs) are the principal antigen-presenting cells for T lymphocytes, and direct both the quality and the quantity of the immune responses. DCs in peripheral tissues continuously sample the surrounding environment and migrate to regional lymph nodes where they present the antigens captured in the periphery to naïve T lymphocytes. By expressing high levels of co-stimulatory molecules essential for naïve T-cell activation, DCs efficiently direct expansion and then differentiation of antigen-specific effector T cells. In addition DCs, by secreting different cytokines at the time of antigen presentation, provide an additional signal instructing naïve T cells to differentiate into diversely specialised subsets for appropriate adaptive immune response. Given the central role in the activation and regulation of immune responses DCs represent an ideal target for immune system manipulation aimed at either boost responses to pathogens and tumoural cells or reducing self-harmful autoimmune reactions.

Key Concepts:

  • Dendritic cells are components of the innate immune system specialised in antigen presentation and cytokine secretion.
  • Dendritic cells efficiently capture molecules in the surrounding environment including foreign and self-antigens.
  • Dendritic cells are activated by molecules signalling infection or tissue injury.
  • Molecules associated with potentially pathogenic organisms are recognised by Toll-like receptors expressed by dendritic cells.
  • Dendritic cells have the unique ability to prime naïve T lymphocyte to proliferate and differentiate into effector T cells.
  • Plasmacytoid dendritic cells’ primary task is the rapid and abundant release of type I interferons, in response to viral infection.

Keywords: immune response; antigen-presenting cell; dendritic cell

Figure 1. Development of the different subsets of DCs and outcome of antigen presentation: two different lineages of DCs originate from haematopoietic myeloid and lymphoid progenitors in the bone marrow. The myeloid lineage gives rise to interstitial DCs and Langerhans cells. Plasmacytoid DCs stem from a lymphoid precursor and can populate peripheral tissues and secondary lymphoid organs. Depending on the activation state of DCs, antigen presentation can result in the promotion of immune responses or tolerance. Under physiologic conditions (steady state), DCs reach the secondary lymphoid organs at a low rate and in an immature state and promote tolerance. In contrast, during activation in peripheral tissues due to infection or inflammation, fully mature DCs massively migrate to T-cell areas of secondary lymphoid organs and prime naïve T cells to differentiate into effector and memory cells.
Figure 2. Principal differences between immature and mature DCs. Immature DCs are capable of antigen internalisation, but express low levels of MHC class II (predominantly intracellular) and co-stimulatory molecules. Immature DCs are rather inefficient at stimulating naïve T cells. Mature DCs downregulate antigen capture capacity, synthesise and export to the surface high amounts of MHC class II molecules and express high levels of co-stimulatory molecules, thus acquiring high T-cell stimulating activity. In addition, mature DCs release cytokines (e.g. IL-12p70) that are important for directing T-cell differentiation. Maturation of DCs is driven initially by environmental signals such as bacterial products and cytokines, and then by signals provided by T cells.
Figure 3. Clusters of DCs and T lymphocytes. DCs are shown in green (CD1a+) and T lymphocytes in orange (CD3+). Each DC can simultaneously engage numerous T lymphocytes.
Figure 4. Langerhans cells direct adaptive immune response to antigen in the skin.
close
 References
    Banchereau J and Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392: 245–252.
    Heath WR (2004) Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunological Review 199: 9–26.
    Hoshino K and Kaisho T (2008) Nucleic acid sensing Toll-like receptors in dendritic cells. Current Opinion in Immunology 20: 408–413.
    Joffre O, Nolte MA, Spörri R et al. (2009) Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunological Reviews 227: 234–247.
    Liu YJ (2005) Professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annual Review of Immunology 23: 275–306.
    Medzhitov R (2007) Recognition of microorganism and activation of the immune response. Nature 449: 819–826.
    Melief CJ (2008) Cancer immunotherapy by dendritic cells. Immunity 29: 372–383.
    Randolph GJ, Ochando J and Partida-Sánchez S (2008) Migration of dendritic cell subsets and their precursors. Annual Review of Immunology 26: 293–316.
    Shortman K and Liu YJ (2002) Mouse and human dendritic cell subtypes. Nature Reviews in Immunology 2: 151–161.
    Shortman K and Naik SH (2007) Steady-state and inflammatory dendritic-cell development. Immunology 7: 19–30.
    Steinman RM and Banchereau J (2007) Taking dendritic cells into medicine. Nature 449: 419–426.
    Steinman RM, Hawiger D and Nussenzweig MC (2003) Tolerogenic dendritic cells. Annual Review of Immunology 21: 685–711.
 Further Reading
    Degli-Esposti MA and Smyth MJ (2005) Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nature Reviews in Immunology 2: 112–124.
    Heath WR and Carbone FR (2009) Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nature Immunology 10: 1237–1244.
    McColl SR (2002) Chemokines and dendritic cells: a crucial alliance. Immunology and Cell Biology 80: 489–496.
    Merad M and Manz MG (2009) Dendritic cell homeostasis. Blood 113: 3418–3427.
    Morelli AE and Thomson AW (2007) Tolerogenic dendritic cells and the quest for transplant tolerance. Nature Reviews in Immunology 8: 610–621.
    Nestle FO, Di Meglio P, Qin JZ and Nickoloff BJ (2009) Skin immune sentinels in health and disease. Nature Reviews in Immunology 10: 679–691.
    Steinman RM (2007) Dendritic cells: understanding immunogenicity. European Journal of Immunology 37: S53–S60.
Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Girolomoni, Giampiero, and la Sala, Andrea(Jun 2010) Dendritic Cells (T‐lymphocyte Stimulating). In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1002/9780470015902.a0001125.pub3]